Figure 1From: Leflunomide inhibits the apoptosis of human embryonic lung fibroblasts infected by human cytomegalovirusCell changes in cell morphology at 24 hours and 48 hours. (A) Control group (normal human embryonic lung fibroblast at 24 hours, microscope × 200). (B) Control group (normal human embryonic lung fibroblast at 48 hours, microscope × 400). (C) Human cytomegalovirus (HCMV) group (human embryonic lung fibroblast infected with HCMV at 24 hours, microscope × 200). (D) HCMV group (human embryonic lung fibroblast infected with HCMV at 48 hours, microscope × 400). (E) Ganciclovir (GCV) + HCMV group (GCVadded to the human embryonic lung fibroblast infected with HCMV at 24 hours, microscope × 200). (F) GCV + HCMV group (GCV added to the human embryonic lung fibroblast infected with HCMV at 48 hours, microscope × 400). (G) Leflunomide (LEF) + HCMV group (LEF added to human embryonic lung fibroblast infected with HCMV at 24 hours, microscope × 200). (H) LEF + HCMV group (LEF added to the human embryonic lung fibroblast infected with HCMV at 48 hours, microscope × 400).Back to article page